Clinical trial
Preoperative Hyperbaric Oxygen Therapy (HBOT) vs. Non Preoperative HBOT in Patients Undergoing Pancreaticoduodenectomy for Premalignant, and Malignant Tumors of the Common Bile Duct, Periampullary and Duodenum
NCT02575014 is registered in ClinicalTrials.gov with Florida Hospital Tampa Bay Division as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preoperative Hyperbaric Oxygen Therapy (HBOT) vs. Non Preoperative HBOT in Patients Undergoing Pancreaticoduodenectomy for Premalignant, and Malignant Tumors of the Common Bile Duct, Periampullary and Duodenum
- Lead sponsor
- Florida Hospital Tampa Bay Division
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2013
- Completion date
- December 31, 2022
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
common bile duct neoplasms, duodenal neoplasms, periampullary tumor